参考文献/References:
[1]阮玉瑛,周涛,李冰.原发性高血压患者血浆致动脉粥样硬化指数与动脉硬化进展的相关性研究[J].心肺血管病杂志,2023,42(5):406-410,415.[2]Ivankova A,Kuzminova N.Metabolic status in patients with essential hypertension and different forms of concomitant extrasystoles[J].Atherosclerosis,2021,331(1):229.[3]刘言薇.基于“心-脾-肠”理论探讨健脾化浊调脂颗粒治疗动脉粥样硬化的机制研究[D].南昌:江西中医药大学,2019.[4]邓利群,王茜,张冬花,等.老年高血压患者颈动脉斑块检出率与缺血性脑卒中的相关性[J].中华老年心脑血管病杂志,2021,23(8):850-853.[5]焦红翠,国二宁,宋莉红.颈动脉彩超在糖尿病合并脑梗死患者颈动脉斑块诊断中的意义[J].神经损伤与功能重建,2021,16(2):121-122.[6]刘春红,王秀艳,赵惠荣,等.24小时动态血压监测与血管超声在高龄H型高血压伴颈动脉粥样硬化诊断中的应用价值探析[J].临床和实验医学杂志,2020,19(22):2459-2462.[7]高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,中国高血压防治指南修订委员会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.[8]Iliakis P,Tsioufis C,Dimitriadis K,et al.Changes in arterial stiffness independently predict stroke in patients with essential hypertension: Data from a 8-year-follow-up study[J].European Heart Journal,2019,40(1):805.[9]尚晖,李勋.H型高血压患者颈动脉粥样硬化相关危险因素分析[J].中国动脉硬化杂志,2019,27(11):969-974,984.[10]Roca F,Bellien J,Iacob M,et al.Endothelium-dependent adaptation of arterial wall viscosity during blood flow increase is impaired in essential hypertension[J].Atherosclerosis,2019,285:102-107.[11]Nakano H,Tomiyama H,Fujii M,et al.The associations among arterial stiffness, endothelial dysfunction and the progression of carotid atherosclerosis in hypertensive subjects with/without carotid atherosclerosis[J].European Heart Journal,2020,41(2):117-121.[12]李红艳,付雪莲,李延新.颈部血管彩超与磁共振在诊断颈动脉狭窄中的应用比较[J].中国CT和MRI杂志,2018,16(12):24-26.[13]王旭东.颈动脉彩超检测粥样斑块对预防缺血性脑卒中的意义[J].中国实验诊断学,2018,22(10):1705-1707.[14]左宗菊,刘扬,孙医学.经颅多普勒与颈动脉彩超在后循环缺血病变粥样硬化斑块中的应用[J].蚌埠医学院学报,2018,43(12):1636-1638.[15]黎燕飞,刘华敢.高频彩超与多层螺旋CT诊断颈动脉粥样硬化斑块的对照分析[J].中国数字医学,2018,13(8):116-117,42.[16]Sedaghat S,van Sloten TT,Laurent S,et al.Common Carotid Artery Diameter and Risk of Cardiovascular Events and Mortality: Pooled Analyses of Four Cohort Studies[J].Hypertension,2018,72(1):85-92.[17]Kotruchin P,Hoshide S,Kario K.Carotid atherosclerosis and the association between nocturnal blood pressure dipping and cardiovascular events[J].J Clin Hypertens (Greenwich),2018,20(3):450-455.[18]Gapon L,Vetoshkin A,Shurkevich N,et al.INFLUENCE OF RISK FACTORS AND ARTERIAL HYPERTENSION ON THE SUBCLINICAL CAROTID ATHEROSCLEROSIS IN THE ARCTIC WATCH[J].Journal of Hypertension,2019,37:e230.[19]熊羽佳.心肌梗死合并高血压患者超声检查颈动脉粥样硬化狭窄及斑块分布研究[J].中国医刊,2018,53(10):1144-1147.[20]唐清华,罗开琴.彩色多普勒超声在心肌梗死合并高血压病患者颈动脉粥样硬化狭窄程度及斑块分布检测中的应用[J].解放军医药杂志,2019,31(9):44-47.[21]韩珊珊,王艳丽,武美丽,等.颈动脉彩超对冠状动脉粥样硬化患者的诊断价值[J].中国实验诊断学,2018,22(4):645-646.[22]回亚男,刘梦堃,王焕程.颈动脉彩色多普勒超声检查老年女性高血压患者颈动脉病变与血压变异性的相关性研究[J].中国超声医学杂志,2018,34(12):1061-1065.
相似文献/References:
[1]段淑婷,王义围,王兆鹏.高血压病合并糖调节受损患者血压变异性的相关研究[J].医学信息,2018,31(05):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
DUAN Shu-ting,WANG Yi-wei,WANG Zhao-peng.Study on Blood Pressure Variability in Patients with Hypertension Complicated with Impaired Glucose Regulation[J].Journal of Medical Information,2018,31(12):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
[2]熊依良.奥美沙坦酯氢氯噻嗪片治疗轻中度原发性高血压的疗效及安全性分析[J].医学信息,2018,31(19):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
XIONG Yi-liang.Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Tablets in the Treatment of Mild to Moderate Essential Hypertension[J].Journal of Medical Information,2018,31(12):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
[3]李信明,刘春梅,任正强,等.供需平衡视角下原发性高血压的病机与防治[J].医学信息,2018,31(19):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
LI Xin-Ming,LIU Chun-Mei,REN Zheng-Qiang,et al.Pathogenesis and Prevention of Essential Hypertension from the Perspective of Supply and Demand Balance[J].Journal of Medical Information,2018,31(12):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
[4]穆大明.厄贝沙坦氢氯噻嗪与福辛普利治疗原发性高血压的疗效观察[J].医学信息,2019,32(03):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
MU Da-ming.Efficacy of Irbesartan Hydrochlorothiazide and Fosinopril in the Treatment of Essential Hypertension[J].Journal of Medical Information,2019,32(12):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
[5]潘建鑫.高血压患者血小板/淋巴细胞比值与颈动脉粥样硬化的相关性分析[J].医学信息,2020,33(05):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
Pan Jianxin.Correlation analysis of platelet/lymphocyte ratio and carotid atherosclerosisin patients with primary hypertension[J].Journal of Medical Information,2020,33(12):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
[6]谢祥红.AngⅡ、ET-1对高血压患者病情发生发展的影响[J].医学信息,2020,33(16):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]
XIE Xiang-hong.Effects of AngⅡ and ET-1 on the Occurrence and Development of Hypertension Patients[J].Journal of Medical Information,2020,33(12):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]
[7]张新艳,姜国清.颈动脉超声及CT测定粥样斑块诊断缺血性脑卒中的作用[J].医学信息,2020,33(21):160.[doi:10.3969/j.issn.1006-1959.2020.21.050]
ZHANG Xin-yan,JIANG Guo-qing.The Role of Carotid Ultrasound and CT in the Diagnosis of Cerebral Ischemic Stroke[J].Journal of Medical Information,2020,33(12):160.[doi:10.3969/j.issn.1006-1959.2020.21.050]
[8]刘 柳,吕风华.原发性高血压患者脉压与左心室肥厚及射血分数保留的心衰的相关性[J].医学信息,2021,34(01):112.[doi:10.3969/j.issn.1006-1959.2021.01.029]
LIU Liu,LYU Feng-hua.Correlation of Pulse Pressure with Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction in Patients with Essential Hypertension[J].Journal of Medical Information,2021,34(12):112.[doi:10.3969/j.issn.1006-1959.2021.01.029]
[9]魏 炜.奥美沙坦酯和坎地沙坦酯治疗原发性高血压的效果比较[J].医学信息,2021,34(14):160.[doi:10.3969/j.issn.1006-1959.2021.14.045]
WEI Wei.Comparison of the Effects of Olmesartan Medoxomil and Candesartan Cilexetil in the Treatment of Essential Hypertension[J].Journal of Medical Information,2021,34(12):160.[doi:10.3969/j.issn.1006-1959.2021.14.045]
[10]郑艳芳,郭军霞,张永春.原发性高血压合并阵发性心房颤动的危险因素分析[J].医学信息,2021,34(22):51.[doi:10.3969/j.issn.1006-1959.2021.22.014]
ZHENG Yan-fang,GUO Jun-xia,ZHANG Yong-chun.Risk Factors Analysis of Essential Hypertension Complicated with Paroxysmal Atrial Fibrillation[J].Journal of Medical Information,2021,34(12):51.[doi:10.3969/j.issn.1006-1959.2021.22.014]